{"id":"bupivacaine-liposomal-injectable-suspension","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypotension"},{"rate":null,"effect":"Bradycardia"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Systemic toxicity (CNS and cardiac effects at high doses)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Bupivacaine is an amide-type local anesthetic that inhibits sodium influx into nerve cells, preventing depolarization and conduction of nerve impulses. The liposomal formulation encapsulates bupivacaine in lipid vesicles, which provides sustained release of the drug and extends the duration of anesthesia compared to conventional bupivacaine solutions, reducing the need for repeated dosing.","oneSentence":"Bupivacaine liposomal injectable suspension is a local anesthetic that blocks sodium channels in nerve cell membranes, with prolonged duration of action due to encapsulation in liposomes.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:33:26.656Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Local anesthesia for infiltration, nerve block, and epidural anesthesia"},{"name":"Postoperative pain management"}]},"trialDetails":[{"nctId":"NCT05044468","phase":"PHASE2","title":"EXPAREL or Lidocane as Local Anesthetic in Patients Undergoing Pleuroscopy With Pleural Biopsy and Indwelling Pleural Catheter Placement","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2021-03-23","conditions":"Malignant Pleural Neoplasm","enrollment":80},{"nctId":"NCT03214510","phase":"PHASE3","title":"Thoracic Epidural Analgesia or Four-Quadrant Transversus Abdominus Plane Block in Reducing Pain in Patients Undergoing Liver Surgery","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2017-10-04","conditions":"Liver and Intrahepatic Bile Duct Disorder","enrollment":101},{"nctId":"NCT07212114","phase":"PHASE3","title":"Efficacy of EXPAREL vs. Bupivacaine","status":"RECRUITING","sponsor":"Emory University","startDate":"2025-11-17","conditions":"Total Ankle Arthroplasty, Postsurgical Analgesia","enrollment":104},{"nctId":"NCT06077422","phase":"PHASE2, PHASE3","title":"Exparel vs. Marcaine ESP Block for Post-cardiac Surgical Pain","status":"ENROLLING_BY_INVITATION","sponsor":"Rutgers, The State University of New Jersey","startDate":"2024-01-11","conditions":"Pain, Postoperative, Opioid Use, Perioperative Complication","enrollment":150},{"nctId":"NCT06411795","phase":"PHASE2","title":"Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy","status":"RECRUITING","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2023-11-10","conditions":"Duodenal Neoplasm, Pancreatic Neoplasm","enrollment":78},{"nctId":"NCT04189783","phase":"PHASE2","title":"Repeat or Single Quadratus Lumborum Block for the Reduction of Opioid Prescriptions After Surgery in Retroperitoneal Sarcoma Patients (\"RESQU-SARC\" Trial)","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2020-06-08","conditions":"Retroperitoneal Sarcoma","enrollment":113},{"nctId":"NCT07092566","phase":"PHASE3","title":"R.E.C.K vs Exparel in Robotic Nephrectomy","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2025-11-14","conditions":"Renal Carcinoma, Nephrectomy / Methods, Pain Management","enrollment":170},{"nctId":"NCT07222748","phase":"PHASE3","title":"A Study of TLC590 for Postsurgical Pain Following Bunionectomy","status":"RECRUITING","sponsor":"TLC Biopharmaceuticals, Inc.","startDate":"2025-11-17","conditions":"Postoperative Pain","enrollment":300},{"nctId":"NCT06471348","phase":"NA","title":"Postoperative Pain Control in AIS Using Liposomal Bupivacaine vs. 0.25% Bupivacaine With Epinephrine","status":"RECRUITING","sponsor":"Boston Children's Hospital","startDate":"2025-08-15","conditions":"Post Operative Pain, Spinal Fusion","enrollment":128},{"nctId":"NCT05171179","phase":"PHASE3","title":"The Use of Pecs Blocks in Combination With Exparel in Breast Reconstruction Surgery","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2021-10-22","conditions":"Mammaplasty","enrollment":60},{"nctId":"NCT02128646","phase":"PHASE4","title":"Liposomal Bupivacaine (Exparel) for Postoperative Pain Control for Open and Laparoscopic Abdominal Hernia Repair","status":"COMPLETED","sponsor":"University of Kansas Medical Center","startDate":"2014-04","conditions":"Pain","enrollment":19},{"nctId":"NCT05862792","phase":"","title":"Liposomal Bupivacaine and Transoral Robotic Surgery","status":"RECRUITING","sponsor":"Geisinger Clinic","startDate":"2023-06-01","conditions":"Oropharyngeal Cancer, Dysphagia, Oropharyngeal, Post Operative Pain","enrollment":80},{"nctId":"NCT06547255","phase":"PHASE4","title":"Exparel Versus Bupivacaine in Post-operative Pain Control","status":"COMPLETED","sponsor":"Case Western Reserve University","startDate":"2024-08-21","conditions":"Liposomal Bupivacaine","enrollment":82},{"nctId":"NCT05157841","phase":"PHASE3","title":"Phase 3, Sciatic Nerve Block With EXPAREL for Subjects Undergoing Bunionectomy","status":"COMPLETED","sponsor":"Pacira Pharmaceuticals, Inc","startDate":"2022-02-15","conditions":"Bunionectomy, Hallux Valgus","enrollment":185},{"nctId":"NCT03290196","phase":"PHASE4","title":"The Effect of EXPAREL® on Postsurgical Pain, and the Use of Narcotics","status":"TERMINATED","sponsor":"Andrews Research & Education Foundation","startDate":"2015-09-03","conditions":"Rotator Cuff Tear","enrollment":13},{"nctId":"NCT05664958","phase":"PHASE4","title":"ESP Block for Post Cesarean Analgesia","status":"COMPLETED","sponsor":"Duke University","startDate":"2023-04-17","conditions":"Cesarean Section Complications","enrollment":150},{"nctId":"NCT03745040","phase":"PHASE4","title":"Liposomal Bupivacaine in One-level Instrumented Posterior Spinal Fusion","status":"SUSPENDED","sponsor":"Allina Health System","startDate":"2019-01-26","conditions":"Lumbar Spinal Stenosis, Lumbar Disc Herniation, Lumbar Disc Disease","enrollment":60},{"nctId":"NCT05139030","phase":"PHASE3","title":"Phase 3 Adductor Canal Block With EXPAREL in Subjects Undergoing Primary Unilateral Total Knee Arthroplasty","status":"COMPLETED","sponsor":"Pacira Pharmaceuticals, Inc","startDate":"2022-01-18","conditions":"Knee Osteoarthritis, Pain Management","enrollment":167},{"nctId":"NCT04258631","phase":"PHASE4","title":"Liposomal Bupivacaine With or Without Hydromorphone for the Improvement of Pain Control After Laparotomy in Patients With Gynecological Malignancies","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2020-07-09","conditions":"Malignant Female Reproductive System Neoplasm","enrollment":105},{"nctId":"NCT02058303","phase":"PHASE4","title":"Study of A Long Lasting Local Anesthestic for Hand, Wrist or Finger Surgery","status":"TERMINATED","sponsor":"Jose Soberon, MD","startDate":"2014-02","conditions":"Hand Injuries, Wrist Injuries, Finger Injuries","enrollment":37},{"nctId":"NCT04232306","phase":"PHASE4","title":"Liposomal Bupivacaine + Bupivacaine vs. Bupivacaine Alone on Opioid Use After Elective c/Section","status":"WITHDRAWN","sponsor":"Wake Forest University Health Sciences","startDate":"2024-03","conditions":"Postoperative Pain, Cesarean Section","enrollment":""},{"nctId":"NCT06274008","phase":"PHASE1","title":"Exparel vs. ACB With Bupivacaine for ACL Reconstruction","status":"UNKNOWN","sponsor":"Children's Hospital of Orange County","startDate":"2023-10-12","conditions":"ACL Tear, Opioid Misuse, Pain","enrollment":96},{"nctId":"NCT04293809","phase":"PHASE1","title":"Study to Evaluate the Pharmacokinetics and Safety of EXPAREL Administered as a Pectoral Plane Block in Women Undergoing Breast Augmentation","status":"COMPLETED","sponsor":"Pacira Pharmaceuticals, Inc","startDate":"2019-12-19","conditions":"Breast Augmentation","enrollment":30},{"nctId":"NCT03769714","phase":"PHASE4","title":"EXPAREL for Minimally Invasive Supracervical Hysterectomies","status":"COMPLETED","sponsor":"Maimonides Medical Center","startDate":"2018-10-01","conditions":"Pain","enrollment":60},{"nctId":"NCT03972397","phase":"PHASE4","title":"Intercostal Nerve Cryoablation for Postoperative Pain Management","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2019-07-15","conditions":"Pain, Postoperative","enrollment":20},{"nctId":"NCT04518462","phase":"PHASE3","title":"Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of EXPAREL, EXPAREL Admixed With Bupivacaine HCl vs. Bupivacaine HCl Administered as Combined Sciatic and Saphenous Nerve Blocks for Postsurgical Analgesia in Subjects Undergoing Lower Extremity Surgeries","status":"COMPLETED","sponsor":"Pacira Pharmaceuticals, Inc","startDate":"2020-10-20","conditions":"Lower Extremity Surgery, Bunion, Metatarsophalangeal Fushion","enrollment":121},{"nctId":"NCT03885596","phase":"PHASE2","title":"Open-Label CA-008 (Vocacapsaicin) in Bunionectomy","status":"COMPLETED","sponsor":"Concentric Analgesics","startDate":"2019-03-25","conditions":"Pain","enrollment":36},{"nctId":"NCT03015961","phase":"PHASE4","title":"Phase 4, Controlled Study in Adult Subjects Undergoing Primary, 1-2 Level, Open Lumbar Spinal Fusion Surgery","status":"TERMINATED","sponsor":"Pacira Pharmaceuticals, Inc","startDate":"2017-02-21","conditions":"Postoperative Pain Management","enrollment":38},{"nctId":"NCT03541941","phase":"PHASE4","title":"Exparel vs. Bupivacaine Hydrochloride vs. Placebo for Hernia Repair","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2018-07-03","conditions":"Analgesia, Postoperative","enrollment":164},{"nctId":"NCT01802411","phase":"PHASE3","title":"Intercostal Nerve Block With Liposome Bupivacaine in Subjects Undergoing Posterolateral Thoracotomy","status":"COMPLETED","sponsor":"Pacira Pharmaceuticals, Inc","startDate":"2012-12","conditions":"Posterolateral Thoracotomy, Postoperative Pain","enrollment":191},{"nctId":"NCT02210247","phase":"PHASE1","title":"Safety and Pharmacokinetics Study of Redosing EXPAREL in Healthy Volunteers","status":"COMPLETED","sponsor":"Pacira Pharmaceuticals, Inc","startDate":"2014-08","conditions":"Healthy Volunteers","enrollment":60},{"nctId":"NCT01919190","phase":"PHASE4","title":"EXPAREL Administered by Infiltration Into the TAP for Prolonged Postsurgical Analgesia in Lower Abdominal Surgeries","status":"TERMINATED","sponsor":"Pacira Pharmaceuticals, Inc","startDate":"2013-08","conditions":"Pain","enrollment":67},{"nctId":"NCT01582477","phase":"PHASE4","title":"TAP-patients With Robotic Assisted Lap Prostatectomy","status":"COMPLETED","sponsor":"Pacira Pharmaceuticals, Inc","startDate":"2012-03","conditions":"Postsurgical Pain, Analgesia, Prostatectomy","enrollment":24},{"nctId":"NCT03420638","phase":"PHASE4","title":"EXPAREL Post-tonsillectomy Clinical Trial","status":"UNKNOWN","sponsor":"Paul Hoff","startDate":"2018-02-15","conditions":"Tonsillectomy","enrollment":38},{"nctId":"NCT03080142","phase":"PHASE4","title":"TAP Block Catheters vs Liposomal Bupivacaine for Pain Control After Colorectal Surgery","status":"COMPLETED","sponsor":"University of California, Davis","startDate":"2017-03-01","conditions":"Colorectal Surgery, TAP Blocks","enrollment":86},{"nctId":"NCT02353754","phase":"PHASE4","title":"Evaluation of the Safety and Efficacy of EXPAREL When Administered Into the TAP in Subjects Undergoing Cesarean Section","status":"TERMINATED","sponsor":"Pacira Pharmaceuticals, Inc","startDate":"2015-05","conditions":"Pain","enrollment":12},{"nctId":"NCT02199574","phase":"PHASE4","title":"Pharmacokinetic Evaluation of EXPAREL in Adults Undergoing Tonsillectomy","status":"COMPLETED","sponsor":"Pacira Pharmaceuticals, Inc","startDate":"2014-08","conditions":"Pain","enrollment":12},{"nctId":"NCT01801124","phase":"PHASE4","title":"EXPAREL Infiltrated Into the TAP for Postoperative Analgesia in Unilateral Abdominal Hernia Repair","status":"COMPLETED","sponsor":"Pacira Pharmaceuticals, Inc","startDate":"2012-04","conditions":"Hernia","enrollment":13},{"nctId":"NCT01919606","phase":"PHASE4","title":"EXPAREL Administered Into the TAP for Analgesia in Subjects Undergoing Open Total Abdominal Hysterectomy","status":"TERMINATED","sponsor":"Pacira Pharmaceuticals, Inc","startDate":"2012-08","conditions":"Postoperative Pain","enrollment":1},{"nctId":"NCT04169256","phase":"PHASE1","title":"Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profile of HYR-PB21 in Healthy Volunteers","status":"COMPLETED","sponsor":"Fruithy Medical Pty Ltd","startDate":"2020-03-03","conditions":"Acute Postoperative Pain","enrollment":32},{"nctId":"NCT02659501","phase":"NA","title":"Liposomal Bupivacaine in Implant Based Breast Reconstruction","status":"TERMINATED","sponsor":"Loma Linda University","startDate":"2015-07","conditions":"Breast Cancer, Postoperative Pain","enrollment":24},{"nctId":"NCT04002089","phase":"PHASE1","title":"Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety, of EXPAREL Administered as Sciatic Nerve Block (In Popliteal Fossa), for Postsurgical Analgesia in Subjects Undergoing Bunionectomy","status":"COMPLETED","sponsor":"Pacira Pharmaceuticals, Inc","startDate":"2019-07-26","conditions":"Bunion","enrollment":45},{"nctId":"NCT02052557","phase":"PHASE4","title":"The Effect of Exparel on Post Operative Pain and Narcotic Use After Colon Surgery","status":"COMPLETED","sponsor":"Des Moines University","startDate":"2013-02","conditions":"Post-operative Pain, Colon Cancer, Diverticulitis","enrollment":51},{"nctId":"NCT02713490","phase":"PHASE4","title":"Local Infiltration Analgesia With and Without EXPAREL Following Total Knee Arthroplasty","status":"COMPLETED","sponsor":"Pacira Pharmaceuticals, Inc","startDate":"2016-04-18","conditions":"Pain","enrollment":140},{"nctId":"NCT02517905","phase":"PHASE3","title":"Evaluation of EXPAREL for Prolonged Postsurgical Analgesia in Subjects Undergoing Third Molar Extraction","status":"COMPLETED","sponsor":"Pacira Pharmaceuticals, Inc","startDate":"2015-08","conditions":"Dental Pain","enrollment":166},{"nctId":"NCT01683071","phase":"PHASE2, PHASE3","title":"Femoral Nerve Block With Liposome Bupivacaine for Postsurgical Analgesia Following Total Knee Arthroplasty","status":"COMPLETED","sponsor":"Pacira Pharmaceuticals, Inc","startDate":"2012-09","conditions":"Postoperative Pain","enrollment":297},{"nctId":"NCT02713230","phase":"PHASE3","title":"Efficacy, Safety, and Pharmacokinetics of Brachial Plexus Block With EXPAREL in Shoulder Surgery","status":"COMPLETED","sponsor":"Pacira Pharmaceuticals, Inc","startDate":"2016-05-09","conditions":"Pain","enrollment":156},{"nctId":"NCT02713178","phase":"PHASE3","title":"Efficacy, Safety, and Pharmacokinetics of Femoral Nerve Block With EXPAREL in Total Knee Arthroplasty","status":"COMPLETED","sponsor":"Pacira Pharmaceuticals, Inc","startDate":"2016-06-03","conditions":"Pain","enrollment":232},{"nctId":"NCT03318757","phase":"PHASE4","title":"Bupivacaine Liposomal Injectable Suspension, Pain and Narcotic Use After Elective Orthognathic Surgery","status":"WITHDRAWN","sponsor":"Boston University","startDate":"2020-09","conditions":"Orthognathic Surgery","enrollment":""},{"nctId":"NCT03838133","phase":"PHASE2","title":"A Study to Evaluate Safety, PK, Efficacy of TLC590 for Postsurgical Pain Management Following Bunionectomy","status":"COMPLETED","sponsor":"Taiwan Liposome Company","startDate":"2019-03-05","conditions":"Hallux Valgus","enrollment":150},{"nctId":"NCT04158102","phase":"PHASE1","title":"Evaluate the Pharmacokinetics and Safety of EXPAREL® Following Subcutaneous Administration in Healthy Chinese Subjects","status":"COMPLETED","sponsor":"Nuance Pharma (shanghai) Co., Ltd","startDate":"2019-11-07","conditions":"Healthy Subjects","enrollment":20},{"nctId":"NCT04102267","phase":"PHASE4","title":"Extended Delivery of Bupivacaine Study in Herniorrhaphy","status":"COMPLETED","sponsor":"Heron Therapeutics","startDate":"2018-07-02","conditions":"Analgesia","enrollment":32},{"nctId":"NCT02356198","phase":"NA","title":"Exparel Transversus Abdominis Plane Block vs Intrathecal Analgesia In Colorectal Surgery","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2015-03","conditions":"Conditions Requiring Colorectal Surgery","enrollment":209},{"nctId":"NCT02652156","phase":"PHASE3","title":"TAP Block for Postoperative Pain Control","status":"TERMINATED","sponsor":"Joshua Herskovic","startDate":"2015-11-01","conditions":"Pain, Postoperative","enrollment":14},{"nctId":"NCT02111746","phase":"PHASE4","title":"PAIN - Postoperative Analgesia INvestigation","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2013-11-20","conditions":"Postoperative Pain","enrollment":350},{"nctId":"NCT02299349","phase":"NA","title":"Bupivacaine Liposome Suspension Versus a Concentrated Multi Drug Periarticular Injection","status":"COMPLETED","sponsor":"TriHealth Inc.","startDate":"2013-08","conditions":"Total Knee Arthroplasty","enrollment":70},{"nctId":"NCT01826851","phase":"PHASE2","title":"Parasternal Nerve Block in Cardiac Patients","status":"COMPLETED","sponsor":"Peter A Knight","startDate":"2013-03","conditions":"Coronary Artery Disease, Pain, Postoperative","enrollment":79},{"nctId":"NCT03001453","phase":"PHASE2","title":"Intraoperative Liposomal Bupivacaine vs. Bupivacaine for Total Hip Replacement Pain Management","status":"COMPLETED","sponsor":"American Hip Institute","startDate":"2014-04","conditions":"Pain, Postoperative","enrollment":107},{"nctId":"NCT02274870","phase":"PHASE4","title":"Liposomal Bupivacaine for Post Operative Pain After Knee Replacement Surgery","status":"COMPLETED","sponsor":"Northwell Health","startDate":"2014-11","conditions":"Post-operative Pain","enrollment":65},{"nctId":"NCT02682498","phase":"PHASE4","title":"Comparing Post-Op Narcotic Usage in Patients Receiving Periarticular Exparel vs. Standard Periarticular Joint Inj","status":"COMPLETED","sponsor":"University of California, Irvine","startDate":"2013-10","conditions":"Arthroplasty, Replacement, Knee","enrollment":38},{"nctId":"NCT02274077","phase":"PHASE4","title":"Transverse Abdominal Plane Anesthesia for Abdominal Wall Reconstruction","status":"WITHDRAWN","sponsor":"Chester Mays","startDate":"2016-01","conditions":"Hernia, Ventral","enrollment":""},{"nctId":"NCT02808728","phase":"PHASE4","title":"Effectiveness of Intraoperative Exparel for Postoperative Pain Control in Total Knee Arthroplasty","status":"UNKNOWN","sponsor":"DeClaire LaMacchia Orthopaedic Institute","startDate":"2014-05","conditions":"Osteoarthritis, Total Knee Arthroplasty, Pain Management","enrollment":100},{"nctId":"NCT02473198","phase":"PHASE3","title":"Femoral Nerve Block Compared to Exparel in Total Knee Replacement","status":"UNKNOWN","sponsor":"The New England Baptist Hospital","startDate":"2014-01","conditions":"Osteoarthritis, Pain","enrollment":312},{"nctId":"NCT02166632","phase":"NA","title":"Postoperative Pain Control Results Using Periarticular Versus Intra-capsular Injection of Bupivacaine Liposome Injectable Suspension in Total Knee Arthroplasty","status":"COMPLETED","sponsor":"Broward Health","startDate":"2014-04","conditions":"Osteoarthritis, Knee","enrollment":50},{"nctId":"NCT01853176","phase":"PHASE4","title":"Exparel vs. Standard Bupivicaine for Abdominoplasty","status":"TERMINATED","sponsor":"Emory University","startDate":"2013-05","conditions":"Pain, Postoperative","enrollment":4},{"nctId":"NCT01582490","phase":"PHASE4","title":"Study of EXPAREL in Patients Undergoing Breast Augmentation","status":"COMPLETED","sponsor":"Pacira Pharmaceuticals, Inc","startDate":"2012-04","conditions":"Mammoplasty, Postoperative Pain","enrollment":19},{"nctId":"NCT02142829","phase":"PHASE4","title":"Pain Control in Bariatric Patients: EXPAREL(R) vs. the On-Q(R) Pain Ball","status":"COMPLETED","sponsor":"Pacira Pharmaceuticals, Inc","startDate":"2012-11","conditions":"Obesity","enrollment":101},{"nctId":"NCT02058290","phase":"PHASE4","title":"A Health Economic Trial in Adult Patients Undergoing Laparoscopic Colectomy","status":"TERMINATED","sponsor":"Pacira Pharmaceuticals, Inc","startDate":"2011-12","conditions":"Bowel Obstruction","enrollment":122},{"nctId":"NCT01509807","phase":"PHASE4","title":"A Health Economic Trial in Adult Patients Undergoing Ileostomy Reversal MA402S23B504","status":"COMPLETED","sponsor":"Pacira Pharmaceuticals, Inc","startDate":"2012-01","conditions":"Retraction of Colostomy","enrollment":33},{"nctId":"NCT01507220","phase":"PHASE4","title":"A Health Economic Trial in Adult Patients Undergoing Open Colectomy MA402S23B301","status":"TERMINATED","sponsor":"Pacira Pharmaceuticals, Inc","startDate":"2012-03","conditions":"Bowel Obstruction","enrollment":2},{"nctId":"NCT01509638","phase":"PHASE4","title":"A Health Economic Trial in Adult Patients Undergoing Ileostomy Reversal MA402S23B501","status":"COMPLETED","sponsor":"Pacira Pharmaceuticals, Inc","startDate":"2012-03","conditions":"Retraction of Colostomy","enrollment":47},{"nctId":"NCT01507233","phase":"PHASE4","title":"A Health Economic Trial in Adult Patients Undergoing Open Colectomy MA402S23B302","status":"TERMINATED","sponsor":"Pacira Pharmaceuticals, Inc","startDate":"2012-05","conditions":"Bowel Obstruction","enrollment":5},{"nctId":"NCT01507246","phase":"PHASE4","title":"Adult Patients Undergoing Open Colectomy MA402S23B303","status":"COMPLETED","sponsor":"Pacira Pharmaceuticals, Inc","startDate":"2011-12","conditions":"Bowel Obstruction","enrollment":42}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":6,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Exparel® (Pacira Pharmacoceuticals)"],"phase":"marketed","status":"active","brandName":"Bupivacaine liposomal injectable suspension","genericName":"Bupivacaine liposomal injectable suspension","companyName":"The University of Texas Health Science Center, Houston","companyId":"the-university-of-texas-health-science-center-houston","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Bupivacaine liposomal injectable suspension is a local anesthetic that blocks sodium channels in nerve cell membranes, with prolonged duration of action due to encapsulation in liposomes. Used for Local anesthesia for infiltration, nerve block, and epidural anesthesia, Postoperative pain management.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}